On Saturday, May 23, 2026
About a third of all approved pharmaceutical target G protein–coupled receptors (GPCRs). The discovery of pharmaceutical compounds for these receptors remains challenging because they are embedded in the cell membrane, and the binding pockets of GPCRs are tightly packed. Many small molecules that target GPCRs have traditionally been identified in nature, and now, with new artificial intelligence–based design methods, miniproteins that target these receptors are being developed, as reported in the article published in Nature (DOI: 10.1038/s41586-026-10656-8).
Researchers from the Institute for Protein Design (IPD), AI protein design company Skape Bio, and other collaborating institutes developed both antagonists and agonists for several GPCRs. The design of agonists is more complex than the design of antagonists because the agonist needs to cause a conformational change that leads to activation of the receptor, not just to its blockade. The designed agonists did this by stabilizing the active form of the receptor.
“GPCRs are very dynamic molecules – sometimes they assume the active state, even though there is no molecule,” says project leader and CEO, Christoffer Norn, of Skape Bio. “When you subsequently arrive with a miniprotein that fits into the active state, you can then lock that one in place.
These receptor-binding proteins are also thought to be useful in the study of the function of GPCRs. Many GPCRs remain unexploited due to the lack of appropriate ligands or tools for the researchers to use, IPD researcher Edin Muratspahić said.
Dawn Scientific, brings innovative solutions to the field of pharmaceutical and biochemical research, supplying the industry with advanced research materials, analytical reagents, and high-quality laboratory chemicals. Research developments in AI-designed GPCR minibinders highlight the increasing need for reliable laboratory materials and precision-driven solutions that support modern pharmaceutical discovery and receptor-targeting studies.
Disclaimer:All the information on this news is published in good faith and for general information purposes only. The information contained in this news might be provided on an “as is” based on Wikipedia, Google, and other scientific articles. We are not liable for any injuries or damages for the use of the information. Please do your own research before you use this information for any purpose.
